A detailed history of All Square Wealth Management LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, All Square Wealth Management LLC holds 186 shares of SAVA stock, worth $797. This represents 0.0% of its overall portfolio holdings.

Number of Shares
186
Previous 186 -0.0%
Holding current value
$797
Previous $2,000 150.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$18.44 - $26.41 $7,376 - $10,564
-400 Reduced 68.26%
186 $3,000
Q4 2023

Feb 14, 2024

BUY
$12.64 - $30.11 $1,112 - $2,649
88 Added 17.67%
586 $13,000
Q3 2021

Nov 12, 2021

BUY
$41.79 - $135.3 $7,772 - $25,165
186 Added 59.62%
498 $31,000
Q1 2021

May 11, 2021

BUY
$7.09 - $87.95 $297 - $3,693
42 Added 15.56%
312 $14,000
Q1 2020

May 12, 2020

BUY
$3.26 - $9.65 $880 - $2,605
270 New
270 $1,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $172M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track All Square Wealth Management LLC Portfolio

Follow All Square Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of All Square Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on All Square Wealth Management LLC with notifications on news.